- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06638645
Prolonged Hospital Stay After Thoracoscopic Anatomical Lung Resections (PROTRACT)
January 13, 2025 updated by: DienstThoracaleEnVasculaireHeelkunde, University Hospital, Ghent
Reasons for Prolonged Hospital Stay After Thoracoscopic Anatomical Lung Resections
In this study, the reasons for prolonged hospital stay after thoracoscopic (video- or robot-assisted) anatomical lung resections are investigated.
Currently, whenever possible, these anatomical lung resections are performed thoracoscopically, as they offer significant improvements in terms of postoperative pain, number of postoperative complications, rehabilitation, tolerance for adjuvant chemotherapy, and length of hospital stay.
The development of an 'Enhanced Recovery After Surgery' (ERAS) protocol for lung surgery has further reduced hospital stay and the need for opioids for analgesia.
Despite the optimal implementation of the ERAS protocol, there are still patients who need to stay in the hospital longer than the median.
The aim of this research is to investigate the reasons for this.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
140
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Liesbeth Desender, MD, PhD
- Phone Number: 3293326148
- Email: liesbeth.desender@uzgent.be
Study Locations
-
-
-
Bruges, Belgium
- Recruiting
- AZ Sint-Jan Brugge-Oostende AV
-
Contact:
- Jan Lesaffer, MD
- Phone Number: 3250452560
- Email: jan.lesaffer@azsintjan.be
-
Contact:
- Jan Lesaffer, MD
-
Ghent, Belgium
- Recruiting
- Ghent University Hospital
-
Contact:
- Liesbeth Desender, MD, PhD
- Phone Number: 3293326148
- Email: liesbeth.desender@uzgent.be
-
Contact:
- Lauren Villeirs, MD
- Email: lauren.villeirs@ugent.com
-
Contact:
- Lauren Villeirs, MD
-
Contact:
- Liesbeth Desender, MD, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients scheduled for thoracoscopic anatomical lung resection.
An estimated 136 patients should be included after power calculation
Description
Inclusion Criteria:
- Patients referred for elective minimally invasive (uniportal or multiportal video- or robot-assisted) anatomical lung resection (lobectomy or segmentectomy)
- Informed consent obtained pre-operatively
- Age 18 years or older
Exclusion Criteria:
- Patients younger than 18 years old
- Traumatic event as indication for lung resection
- Non-anatomical lung resections
- Thoracotomy
- Patients already hospitalized for other pathologies, pre-existent and not related to the lung surgery
- Urgent/emergency procedures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients undergoing a minimally invasive anatomical lung resection
Patients undergoing a minimally invasive anatomical lung resection, receiving perioperative care according to the ERAS protocol for Lung Surgery
|
Perioperative care according to the ERAS protocol for lung surgery
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of hospital stay (days)
Time Frame: immediately after surgery until hospital discharge (1 week on average), up to 3 months
|
The primary objective is to investigate the length of hospital stay of patients undergoing minimally invasive thoracoscopic anatomical lung resection with peri-operative care according to the Enhanced Recovery After Surgery (ERAS) protocol for lung surgery
|
immediately after surgery until hospital discharge (1 week on average), up to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reasons for delayed discharge (more than 2 days postoperatively) identified through daily questionnaires and review of medical records.
Time Frame: immediately after surgery until hospital discharge (1 week on average), up to 3 months
|
|
immediately after surgery until hospital discharge (1 week on average), up to 3 months
|
|
Number, frequency and severity of postoperative complications during hospital stay.
Time Frame: immediately after surgery until hospital discharge (1 week on average), up to 3 months
|
immediately after surgery until hospital discharge (1 week on average), up to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 12, 2024
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
October 1, 2024
First Submitted That Met QC Criteria
October 10, 2024
First Posted (Actual)
October 15, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 13, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- THE-2024-0246
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Lobectomy
-
Ottawa Hospital Research InstituteCompletedLobectomy | Segmentectomy | Pulmonary Air Leak | Wedge ResectionCanada
-
Vanderbilt University Medical CenterCompletedPulmonary Lobectomy | Esophagectomy | Pulmonary Wedge Resection | Pulmonary Pneumonectomy
-
Integra LifeSciences CorporationMedtronic - MITGCompletedLung Disease | Pulmonary LobectomyBelgium, United States, Austria, Netherlands, Switzerland, United Kingdom
-
Tongji HospitalRecruiting
-
AesDex, LLCUnknownLobectomy | SegmentectomyUnited Kingdom
-
University Hospital, LilleMinistry of Health, FranceRecruitingLobectomy | ThyroidectomyFrance
-
Gansu Provincial HospitalNot yet recruitingLobectomy | Dexmedetomidine | Dexamethasone | Ropivacaine
-
Xueying YangUnknownLobectomy | Subxiphoid Uniportal Video-assisted Thoracoscopic SurgeryChina
-
Imperial College Healthcare NHS TrustRoyal Brompton & Harefield NHS Foundation Trust; London Cancer Alliance (North...CompletedLung Cancer | Pulmonary Rehabilitation | LobectomyUnited Kingdom
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingThoracoscopic LobectomyChina
Clinical Trials on VATS/RATS anatomical lung resection
-
Centre hospitalier de l'Université de Montréal...Active, not recruiting
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruiting
-
Second Affiliated Hospital, School of Medicine,...Sir Run Run Shaw Hospital; Shanghai Chest Hospital of Shanghai Jiao Tong UniversityRecruitingLung Cancer, Non-Small CellChina
-
Ruijin HospitalCompleted
-
Istituto Clinico HumanitasFondazione Umberto VeronesiRecruiting
-
Universitair Ziekenhuis BrusselUnknownPostoperative Pain | Inflammatory Response | Lung Cancer | Blood LossBelgium
-
Centre Hospitalier Universitaire, AmiensCompletedLung Cancer | Surgery | Lobectomy | Video-assisted Thoracoscopic Surgery | SurvivalFrance
-
Korea University Guro HospitalNot yet recruitingLung Cancer | Robotics
-
Huazhong University of Science and TechnologyNot yet recruitingHepatocellular Carcinoma by BCLC StageChina
-
University of MilanUnknownOverall Survival | Patients Affected by Hepatocellular Carcinoma | Disease-Free SurvivalItaly